The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ET140202 t-cells: A novel therapy targeting AFP/MHC complex, that is both safe and effective in treating metastatic hepatocellular carcinoma.
 
Chang Liu
No Relationships to Disclose
 
Hong Liu
Employment - Eureka Therapeutics
Leadership - Eureka Therapeutics
Stock and Other Ownership Interests - Eureka Therapeutics
Research Funding - Eureka Therapeutics
Patents, Royalties, Other Intellectual Property - Eureka Therapeutics
Travel, Accommodations, Expenses - Eureka Therapeutics
 
Yun Wang
No Relationships to Disclose
 
Xiaogang Zhang
No Relationships to Disclose
 
Fengling Fan
No Relationships to Disclose
 
Ruitao Wang
No Relationships to Disclose
 
Kai Qu
No Relationships to Disclose
 
Bijan Nejadnik
Employment - Eureka Therapeutics
Leadership - Eureka Therapeutics
Stock and Other Ownership Interests - Eureka Therapeutics
Research Funding - Eureka Therapeutics
Travel, Accommodations, Expenses - Eureka Therapeutics
 
Bingyin Shi
No Relationships to Disclose
 
Cheng Liu
Employment - Eureka Therapeutics (I)
Leadership - Eureka Therapeutics
Stock and Other Ownership Interests - Eureka Therapeutics
Research Funding - Eureka Therapeutics
Patents, Royalties, Other Intellectual Property - Eureka Therapeutics
Travel, Accommodations, Expenses - Eureka Therapeutics